Class Action Lawsuit Against Cardlytics, Inc. - Investor Alert and Recovery Options
Class Action Lawsuit Against Cardlytics, Inc.
On February 14, 2025, law firm Levi & Korsinsky, LLP informed investors about a class action lawsuit targeting Cardlytics, Inc., known by its NASDAQ symbol CDLX. This legal action primarily aims to compensate investors who sustained losses attributed to alleged securities fraud within the timeframe from March 14, 2024, to August 7, 2024.
Overview of the Class Action
The core of the lawsuit hinges on the claim that Cardlytics made misleading or false statements. Specifically, it is alleged that executives at Cardlytics did not disclose critical issues that adversely impacted the company's performance. According to the filed complaint:
- - Rising consumer engagement unexpectedly led to a surge in customer incentives.
- - The company struggled to align its billings with this increased consumer engagement, indicating a potential slowdown in revenue growth.
- - Failures in the Ads Decision Engine resulted in under-delivery of expected budgets and inaccurate billing estimates.
- - Collectively, these failures mean that the optimistic statements made by the company regarding its operational capabilities were fundamentally misleading.
What Investors Need to Know
Cardlytics investors affected by the alleged inconsistencies in statements are encouraged to take action. The deadline for affected individuals to request the court's appointment as lead plaintiff is March 25, 2025. Importantly, sharing in any potential recovery does not necessitate serving as a lead plaintiff.
Levi & Korsinsky assures potential class members that participating entails no cost or financial obligation. Should investors decide to engage, they may be eligible for restitution without upfront fees. This perspective is crucial as it opens avenues for many affected stakeholders to seek justice without worrying about the monetary burden of legal fees.
The Role of Levi & Korsinsky
Levi & Korsinsky has garnered a strong reputation over the last two decades for its dedication to representing shareholders in complex litigation cases. The firm has successfully recovered hundreds of millions of dollars for investors and has established itself as a leader in the securities litigation landscape. With a specialized team of over 70 professionals, it provides robust support for its clientele.
The firm's achievements include ranking consistently among the top 50 securities litigation firms in the United States according to ISS Securities Class Action Services for seven consecutive years. This recognition underscores their expertise and commitment to investor rights.
Next Steps for Affected Investors
Investors who believe they have been adversely impacted should reach out to Levi & Korsinsky. Individuals can submit their information through the designated link provided by the firm or connect directly with attorney Joseph E. Levi via email or phone.
As this situation unfolds, it is essential for Cardlytics investors to stay informed and consider their options for recovery. The potential ramifications of this class action could shape the future for many stakeholders involved with Cardlytics.
Contact Information
For more details about the lawsuit or to take the first steps in participant recovery, affected investors can contact:
- - Joseph E. Levi, Esq.
Phone: (212) 363-7500
- - Levi & Korsinsky, LLP
New York, NY 10004
Website: www.zlk.com
This announcement serves as a crucial alert for investors involved with Cardlytics, encouraging them to assess their position and consider engagement in this significant legal development.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.